Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Merck and Gilead square off in battle of the next-next-gen hep C combos
Fierce Biotech
Thu, 04/23/15 - 09:50 am
Tags:
Merck, Gilead Sciences, hepatitis C, grazoprevir/elbasvir, GS-5816, GS-9857
Gilead Earnings Preview: What You Should Know
Investopedia
Thu, 04/23/15 - 03:14 am
Tags:
earnings, Gilead Sciences
Gilead Buying Vertex? What's The Use?
Seeking Alpha
Thu, 04/23/15 - 03:05 am
Tags:
Gilead Sciences, Vertex Pharmaceuticals, M&A
Gilead Should Buy Vertex Pharma for $45B Now, Analyst Says
TheStreet.com
Tue, 04/21/15 - 09:26 am
Tags:
Gilead Sciences, Vertex Pharma, M&A
Gilead Sciences: Serious Cash Means An Acquisition Could Be Coming Soon
Seeking Alpha
Mon, 04/20/15 - 05:18 pm
Tags:
M&A, Gilead Sciences
Morningstar: Gilead Sciences To Grow Its Hepatitis C Market
Yahoo/Morningstar
Sun, 04/19/15 - 11:48 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
Tags:
AbbVie, AstraZeneca, Biomarin, Bristol-Myers Squibb, Celgene, Gilead Sciences, GSK, Hospira, Jazz Pharmaceuticals, Merck, Seattle Genetics, Shire
Gilead's hep C drugs make it king of the hill in U.S. drug sales
Fierce Pharma
Wed, 04/15/15 - 02:36 pm
Tags:
Gilead Sciences, Harvoni, Sovaldi
Five companies that may be looking to buy Ariad Pharmaceuticals
Bizjournals.com
Wed, 04/15/15 - 08:44 am
Tags:
Ariad Pharmaceuticals, M&A, Roche, Celgene, AbbVie, Gilead Sciences, Pfizer
Gilead Sciences Sparks Analyst Dispute Over Hep C Forecasts
TheStreet.com
Tue, 04/14/15 - 10:26 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Why Merck's Victory Is of Little Concern to Gilead
Investopedia
Sat, 04/11/15 - 10:27 am
Tags:
Merck, Gilead Sciences, grazoprevir/elbasvir, Harvoni, Sovaldi
Gilead: Little Hep C Competition, But What About Pricing?
Barron's
Fri, 04/10/15 - 03:50 pm
Tags:
Gilead Sciences, Merck, AbbVie, hepatitis C
Gilead's Little Tweak Could Produce Big Revenue
Investopedia
Thu, 04/9/15 - 09:42 am
Tags:
Gilead Sciences, HIV, Viread, TAF
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Wed, 04/8/15 - 12:05 pm
Tags:
Merck, AbbVie, hepatitis C, Gilead Sciences, grazoprevir/elbasvir, Harvoni
Gilead's low-dose, high-impact HIV drug heads to the FDA
Bizjournals.com
Wed, 04/8/15 - 10:17 am
Tags:
Gilead Sciences, HIV, FDA, tenofovir, emtricitabine
Gilead's CEO John Martin: Worth The Money?
Seeking Alpha
Mon, 04/6/15 - 06:08 pm
Tags:
Gilead Sciences, John Martin, executive pay
Gilead Q1 Hep C Sales Look Ahead Of Consensus
Barron's
Mon, 04/6/15 - 05:59 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
4 big biopharma deals we might see in 2015
BioPharma Dive
Mon, 04/6/15 - 10:51 am
Tags:
M&A, Merck, Jazz Pharmaceuticals, Shire, Biomarin, Gilead Sciences, Seattle Genetics, Pfizer, Celgene
Actavis seeking FDA Approval to market generic version of Gilead drug
Marketwatch
Fri, 04/3/15 - 10:35 am
Tags:
Actavis, FDA, generics, Gilead Sciences, Letairis, PAH
Should Gilead Sciences, Inc. Be Worried By Achillion Pharmaceuticals?
Motley Fool
Wed, 04/1/15 - 08:45 am
Tags:
Gilead Sciences, Achillion, hepatitis C, Sovaldi, Harvoni

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.